Poniard Pharmaceuticals (PARD) null Earnings

16AprConfirmed
Jul 97
Oct 97
Feb 98
Apr 98
-45.6
-24
-2.4
19.2

Details

Expected EPS
1.2
Actual EPS
-26.4
Surprise EPS
-27.6
Surprise Percent
+2,300%

Description

Poniard Pharmaceuticals (PARD) has reported earnings of -26.4 per share for .

0 Comments

Share your thoughts